NVIDIA backs supplier expansion with $1.1 billion KYEC advance
NVDA
NVIDIA announced supplier expansion plans on October 21, including a $1.1 billion capacity reservation advance to KYEC for new US testing facilities. The commitments address manufacturing constraints that could limit shipments of its AI computing systems.[1]
Capacity targets stretch into 2028
NVIDIA plans to raise substrate capacity for its products by 2.5x over the next three years. Substrates connect chips to the rest of a package, making them another potential constraint alongside chip fabrication.[1]
NVIDIA and Amkor are targeting a greater than 300% increase in interposer wafer capacity in South Korea by the end of 2028. That is a specific advanced packaging target, rather than a forecast for either company’s revenue.[1]
NVIDIA expects its total semiconductor testing capacity to double from calendar 2026 to 2027. KYEC’s new US facilities and equipment are supported by the advance, with high-volume production targeted for April 2027.[1]
Why it matters for NVDA
The stock relevance is execution: stronger demand translates into sales only if suppliers can package and test the systems NVIDIA needs to deliver. Funding capacity in advance can help secure supply, while tying cash to projects that still have to reach production.[1]
These are capacity plans and production targets. They do not establish completed output, customer orders or an earnings upgrade. Investors still need to watch whether the facilities ramp on schedule and whether demand absorbs the additional supply.[1]
NVDA insider trading activity
In open-market trades dated in the last 90 days, no insider bought and 3 insiders sold $967.6M, $21M of it under preset trading plans, per Form 4 filings.
- Mark A. Stevens (Director) sold 4,236,740 shares for $946.6M, last filed Sep 22.
- Timothy S. Teter (EVP, General Counsel and Sec) sold 60,460 shares for $13.3M under a preset plan, last filed Sep 23.
- Colette Kress (EVP & Chief Financial Officer) sold 34,918 shares for $7.6M under a preset plan, last filed Sep 18.
Get NVDA alerts
Set a NVDA price alert, or get one when a fund, insider or politician you follow trades.
NVDA 13F fund activity
In 13F filings received so far for the quarter ended Sep 30, 2026, 1 fund we track made a large change in NVDA: none opened or grew a position by half or more, and 1 cut one by half or more, 1 of them selling out completely.
- Broyhill Asset Management, LLC sold all 7,600 shares, leaving no position.
NVDA Congress trades
11 members of Congress reported 22 trades in NVDA dated in the last 180 days: 11 purchases and 11 sales. Congress reports a value range, not an exact amount.
- Rep. Maria Elvira Salazar (R) bought $1K-$15K on Oct 23, filed Nov 5 (2 trades).
- Rep. Daniel Meuser (R) sold $1K-$15K on Sep 25, filed Nov 5.
- Rep. Pete Sessions (R) sold $15K-$50K on Oct 2, filed Oct 27.
- Rep. Cleo Fields (D) bought $1K-$15K on Oct 1, filed Oct 22 (3 trades).
- Rep. Daniel Meuser (R) sold $1K-$15K on Aug 31, filed Oct 14.
